Raised serum amylase in patients with COVID-19 may not be associated with pancreatitis

A high incidence of pancreatitis in COVID-19 has been reported. Although a high proportion of critically unwell patients with COVID-19 have raised serum amylase levels, this does not necessarily reflect acute pancreatitis or a clinically important pancreatic injury.

Saved in:
Bibliographic Details
Published in:British Journal of Surgery 2021-04, Vol.108 (4), p.e152-e153
Main Authors: Stephens, J R, Wong, J L C, Broomhead, R, Stümpfle, R, Waheed, U, Patel, P, Brett, S J, Soni, S
Format: Article
Language:English
Subjects:
Acute Disease
Amylases - blood
Biomarkers - blood
Comorbidity
COVID-19 - epidemiology
Female
Humans
Incidence
Male
Middle Aged
Pancreatitis - blood
Pancreatitis - epidemiology
Pandemics
Research Letter
SARS-CoV-2
United Kingdom - epidemiology
Citations: Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A high incidence of pancreatitis in COVID-19 has been reported. Although a high proportion of critically unwell patients with COVID-19 have raised serum amylase levels, this does not necessarily reflect acute pancreatitis or a clinically important pancreatic injury.
ISSN:0007-1323
1365-2168
DOI:10.1093/bjs/znaa168